Neuromodulation developer Halo Neuroscience closes its doors; Flow Neuroscience acquires assets

Flow acquires brain stim­u­la­tion tech­nol­o­gy devel­op­er Halo (Med­ical Device Network):

Flow Neu­ro­science has acquired the assets of brain stim­u­la­tion tech­nol­o­gy devel­op­er Halo Neu­ro­science to advance its research into depres­sion and oth­er men­tal health dis­or­der treatments.

The finan­cial details of the deal have not been disclosed.

Using Halo’s research in neu­ro­mod­u­la­tion field, Flow Neu­ro­science plans to enhance its cur­rent med­ical­ly cer­ti­fied tDCS head­set for depres­sion … A form of neu­ro­mod­u­la­tion, tDCS uses con­stant, low direct cur­rent deliv­ered via elec­trodes on the head.

In July 2019, Flow announced that it raised $1.5m towards its tran­scra­nial direct cur­rent stim­u­la­tion (tDCS) device for the treat­ment of depression.

News in Context:

• Halo Neu­ro­science rais­es $13M to fur­ther devel­op and com­mer­cial­ize neu­ro­mod­u­la­tion headset
• tDCS com­ing to an Equinox gym near you: Good, Bad or Depends?
• Impor­tant insights on the grow­ing home use of tDCS brain stim­u­la­tion: old­er-than-expect­ed users, pos­i­tive self-report­ed results for treat­ment of depres­sion but neg­a­tive for self-enhance­ment, and a cou­ple areas of con­cern (severe burns, frequency)
• Pros and Cons of lat­est wear­able tech trend: Mood-alter­ing elec­tri­cal brain stimulation
• Too ear­ly? Brain stim­u­la­tion device Thync fails to get trac­tion in the minds of consumers
• Five rea­sons the future of brain enhance­ment is dig­i­tal, per­va­sive and (hope­ful­ly) bright